Joseph Lacob sold 15,000 shares of Align Technology, Inc. stock.  (NASDAQ:ALGN) Stock

Joseph Lacob sold 15,000 shares of Align Technology, Inc. stock. (NASDAQ:ALGN) Stock

The director of Align Technology, Inc. (NASDAQ:ALGN – Get Your Free Report) Joseph Lacob sold 15,000 shares of the stock in a transaction on Thursday, February 29th. The shares were sold at an average price of $303.22, for a total transaction of $4,548,300.00. Following the completion of the sale, the director now directly owns 131,994 shares in the company, valued at approximately $40,023,220.68. The sale was disclosed in a filing with the Securities and Exchange Commission, which is available on the SEC’s website.

Joseph Lacob also recently made the following trade(s):

  • On Tuesday, February 27th, Joseph Lacob sold 10,000 shares of Align Technology stock. The shares were sold at an average price of $313.01, for a total transaction of $3,130,100.00.

Align the performance of technology stocks

NASDAQ:ALGN opened at $300.01 on Friday. Align Technology, Inc. has a fifty-two week low of $176.34 and a fifty-two week high of $413.20. The stock has a market cap of $22.98 billion, a P/E ratio of 51.55, a P/E/G ratio of 5.44 and a beta of 1.64. The company’s 50-day simple moving average is $282.39, and its 200-day simple moving average is $275.61.

Align Technology (NASDAQ:ALGN – Get Your Free Report ) last posted its earnings results on Wednesday, January 31st. The medical equipment provider reported $1.91 EPS for the quarter, topping analysts’ consensus estimates of $1.78 by $0.13. The company had revenue of $956.73 million during the quarter, compared to analysts’ expectations of $928.57 million. Align Technology had a net margin of 11.52% and a return on equity of 13.88%. On average, analysts predict that Align Technology, Inc. will post 7.65 EPS for the current year.

Align Technology Institutional Trading

A number of institutional investors have recently bought and sold shares of the stock. Sequoia Financial Advisors LLC boosted its stake in Align Technology by 3.1% in the second quarter. Sequoia Financial Advisors LLC now owns 998 shares of the medical equipment provider’s stock valued at $353,000 after buying an additional 30 shares in the last quarter. King Luther Capital Management Corp boosted its stake in Align Technology by 2.4% in the second quarter. King Luther Capital Management Corp now owns 1,298 shares of the medical equipment provider’s stock valued at $459,000 after buying an additional 30 shares in the last quarter. Metropolitan Life Insurance Co NY boosted its stake in Align Technology by 0.7% in the 4th quarter. Metropolitan Life Insurance Co NY now owns 4,202 shares of the medical equipment provider’s stock valued at $886,000 after buying an additional 31 shares in the last quarter. EFG Asset Management Americas Corp. raised its position in Align Technology by 3.6% during the 4th quarter. EFG Asset Management Americas Corp. now owns 1,167 shares of the medical equipment provider’s stock valued at $320,000 after buying an additional 41 shares in the last quarter. Finally, Dfpg Investments LLC raised its position in Align Technology by 3.3% during the 4th quarter. Dfpg Investments LLC now owns 1,327 shares of the medical equipment provider’s stock valued at $340,000 after buying an additional 42 shares in the last quarter. 87.07% of the shares are currently owned by institutional investors and hedge funds.

Analysts set new price targets

Several research analysts recently commented on the stock. Goldman Sachs Group upped their target price on shares of Align Technology from $197.00 to $225.00 and gave the stock a “sell” rating in a research note on Friday, February 2nd. SVB Leerink initiated coverage on shares of Align Technology in a research report on Monday, February 26th. They set a “market perform” rating and a $310.00 target price on the stock. Leerink Partners reissued a “market perform” rating on shares of Align Technology in a research report on Monday, February 26th. Piper Sandler boosted their target price on shares of Align Technology from $290.00 to $335.00 and gave the company an “overweight” rating in a research report on Thursday, February 1st. Finally, UBS Group boosted their target price on shares of Align Technology from $200.00 to $260.00 and gave the company a “neutral” rating in a research report on Tuesday, January 30th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $336.27.

Read our latest report on ALGN stock

Align Technology Company Profile

(Get a free report)

Align Technology, Inc designs, manufactures and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general dentists in the United States, Switzerland, China and internationally. It operates in two segments, Clear Aligner; and imaging systems and CAD/CAM services (systems and services).

More information

Get news and reviews for Align Technology Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Align Technology and related companies with MarketBeat.com ‘s FREE daily email newsletter.

Leave a Comment

Your email address will not be published. Required fields are marked *